Home › Funds › PRELUDE CAPITAL MANAGEMENT, LLC › TEVA
PRELUDE CAPITAL MANAGEMENT, LLC position in TEVA
TEVA PHARMACEUTICAL INDS LTD · Health Care
PRELUDE CAPITAL MANAGEMENT, LLC reported holding 154,970 shares of TEVA (TEVA PHARMACEUTICAL INDS LTD) in its Q2 2026 13F filing — a position valued at US$5.3M, representing 0.42% of its reported portfolio and ranking #41 among its reported holdings. PRELUDE CAPITAL MANAGEMENT, LLC has disclosed TEVA holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PRELUDE CAPITAL MANAGEMENT, LLC's TEVA position evolved
PRELUDE CAPITAL MANAGEMENT, LLC first disclosed a stake in TEVA in Q1 2024 at 16,328 shares (US$230K). The position peaked in Q2 2026 at 154,970 shares, worth US$5.3M. Across 10 filings, PRELUDE CAPITAL MANAGEMENT, LLC increased the stake 6 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 154,970 shares valued at US$5.3M. Notable position changes include a 113% increase in Q1 2025 (shares rose 9% over the following quarter), a 248% increase in Q2 2025 (shares rose 21% over the following quarter), a 53% increase in Q1 2026 (shares rose 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 16.33K | $230.39K | New |
| Q2 2024 | 16.42K | $266.86K | Add |
| Q3 2024 | 16.62K | $299.58K | Add |
| Q4 2024 | 20.68K | $455.79K | Add |
| Q1 2025 | 44.08K | $677.51K | Add |
| Q2 2025 | 153.54K | $2.57M | Add |
| Q3 2025 | 153.39K | $3.10M | Hold |
| Q4 2025 | 101.47K | $3.17M | Reduce |
| Q1 2026 | 154.97K | $4.67M | Add |
| Q2 2026 | 154.97K | $5.25M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TEVA and 13F data
TEVA (TEVA PHARMACEUTICAL INDS LTD) is a Health Care company. 43 other funds we track also report a position in TEVA — the largest reported positions include Harel Insurance Investments & Financial Services Ltd. (US$1.63B), Phoenix Financial Ltd. (US$1.45B), WCM INVESTMENT MANAGEMENT, LLC (US$1.38B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TEVA
- Harel Insurance Investments & Financial Services Ltd. 48.14M sh · $1.63B · Q2 2026
- Phoenix Financial Ltd. 42.93M sh · $1.45B · Q2 2026
- WCM INVESTMENT MANAGEMENT, LLC 41.32M sh · $1.38B · Q2 2026
- Clal Insurance Enterprises Holdings Ltd 40.61M sh · $1.37B · Q2 2026
- MENORA MIVTACHIM HOLDINGS LTD. 39.85M sh · $1.35B · Q2 2026
- Migdal Insurance & Financial Holdings Ltd. 38.92M sh · $1.32B · Q2 2026
- Lingotto Investment Management LLP 20.21M sh · $684.58M · Q2 2026
- Rubric Capital Management LP 15.57M sh · $527.68M · Q2 2026
- Altshuler Shaham Ltd 12.47M sh · $411.81M · Q2 2026
- MEITAV INVESTMENT HOUSE LTD 9.95M sh · $336.88M · Q2 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 6.59M sh · $223.37M · Q2 2026
- Alyeska Investment Group, L.P. 6.26M sh · $212.01M · Q2 2026
More on PRELUDE CAPITAL MANAGEMENT, LLC
FAQ
How long has PRELUDE CAPITAL MANAGEMENT, LLC held TEVA?
PRELUDE CAPITAL MANAGEMENT, LLC has disclosed TEVA holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
What is PRELUDE CAPITAL MANAGEMENT, LLC's current position in TEVA?
As of Q2 2026, PRELUDE CAPITAL MANAGEMENT, LLC holds 154.97K shares of TEVA (TEVA PHARMACEUTICAL INDS LTD), valued at $5.25M, representing 0.42% of its reported portfolio and ranking #41.
Has PRELUDE CAPITAL MANAGEMENT, LLC been buying or selling TEVA?
In the latest 13F filing (Q2 2026), PRELUDE CAPITAL MANAGEMENT, LLC held unchanged its position in TEVA. The position peaked in Q2 2026 at 154.97K shares.
Which other funds hold TEVA?
Other major institutional holders of TEVA include Harel Insurance Investments & Financial Services Ltd., Phoenix Financial Ltd., WCM INVESTMENT MANAGEMENT, LLC, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.